Dr. Michael Ruff, MD

NPI: 1679532576
Total Payments
$8,871
2024 Payments
$518.47
Companies
36
Transactions
346

Payment Breakdown by Category

Food & Beverage$6,371 (71.8%)
Research$2,500 (28.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,371 345 71.8%
Unspecified $2,500 1 28.2%

Payments by Type

General
$6,371
345 transactions
Research
$2,500
1 transactions

Top Paying Companies

Company Total Records Latest Year
Lupin Inc. $2,500 1 $0 (2018)
AstraZeneca Pharmaceuticals LP $952.54 54 $0 (2024)
GlaxoSmithKline, LLC. $898.66 60 $0 (2024)
Regeneron Healthcare Solutions, Inc. $663.07 24 $0 (2024)
Covis Pharma GmBH $414.72 23 $0 (2022)
ALK-Abello, Inc $336.97 19 $0 (2024)
Teva Pharmaceuticals USA, Inc. $280.82 17 $0 (2023)
Pharming Healthcare, Inc. $258.26 13 $0 (2023)
Octapharma USA, Inc. $251.09 6 $0 (2022)
GENZYME CORPORATION $242.13 13 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $518.47 23 Regeneron Healthcare Solutions, Inc. ($158.49)
2023 $1,012 48 Regeneron Healthcare Solutions, Inc. ($233.61)
2022 $648.55 34 Regeneron Healthcare Solutions, Inc. ($88.56)
2021 $1,247 71 Covis Pharma GmBH ($212.80)
2020 $952.78 50 Covis Pharma GmbH ($146.52)
2019 $582.31 34 Covis Pharma B.V. ($123.65)
2018 $3,313 47 Lupin Inc. ($2,500)
2017 $596.59 39 GlaxoSmithKline, LLC. ($137.56)

All Payment Transactions

346 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
11/19/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $22.10 General
Category: Immunology
10/11/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $18.98 General
Category: Immunology
08/28/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $18.70 General
Category: RESPIRATORY
08/21/2024 HOSPIRA, INC. OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG Food and Beverage In-kind items and services $17.75 General
Category: IMMUNOLOGY
08/16/2024 Novartis Pharmaceuticals Corporation XOLAIR (Drug) Food and Beverage In-kind items and services $18.56 General
Category: Pulmonary/Respiratory Diseases
07/18/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $37.68 General
Category: INFLAMMATION AND IMMUNOLOGY
05/30/2024 Takeda Pharmaceuticals U.S.A., Inc. CUVITRU (Biological) Food and Beverage In-kind items and services $25.13 General
Category: IMMUNOLOGY
05/11/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $38.96 General
Category: INFLAMMATION AND IMMUNOLOGY
04/23/2024 Novartis Pharmaceuticals Corporation XOLAIR (Drug) Food and Beverage In-kind items and services $22.98 General
Category: Pulmonary/Respiratory Diseases
04/16/2024 Takeda Pharmaceuticals U.S.A., Inc. TAKHZYRO (Biological) Food and Beverage In-kind items and services $16.89 General
Category: GENETIC DISEASE
04/08/2024 PFIZER INC. OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG Food and Beverage In-kind items and services $17.62 General
Category: IMMUNOLOGY
03/27/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $21.97 General
Category: Respiratory
03/26/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $22.34 General
Category: Respiratory
02/27/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $27.45 General
Category: INFLAMMATION AND IMMUNOLOGY
02/23/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $25.31 General
Category: INFLAMMATION AND IMMUNOLOGY
02/20/2024 Novartis Pharmaceuticals Corporation XOLAIR (Drug) Food and Beverage In-kind items and services $16.07 General
Category: Pulmonary/Respiratory Diseases
02/07/2024 ALK-Abello, Inc Grastek (Drug), Odactra, Ragwitek Food and Beverage In-kind items and services $24.06 General
Category: Allergy and Immunology
02/02/2024 AstraZeneca Pharmaceuticals LP TEZSPIRE (Biological) Food and Beverage In-kind items and services $16.90 General
Category: Respiratory
01/26/2024 Takeda Pharmaceuticals U.S.A., Inc. TAKHZYRO (Biological) Food and Beverage In-kind items and services $19.15 General
Category: GENETIC DISEASE
01/23/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $21.09 General
Category: Respiratory
01/20/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $29.09 General
Category: INFLAMMATION AND IMMUNOLOGY
01/20/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $21.97 General
Category: Respiratory
01/11/2024 HOSPIRA, INC. OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG Food and Beverage In-kind items and services $17.72 General
Category: IMMUNOLOGY
12/19/2023 Pharming Healthcare, Inc. RUCONEST (Biological) Food and Beverage In-kind items and services $18.12 General
Category: BIOLOGIC
12/05/2023 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $20.85 General
Category: Respiratory

Research Studies & Clinical Trials

Study Name Company Amount Records
A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF TWICE DAILY ADMINISTRATION OF FLUTICASONE PROPIONATE 100 MCG AND SALMETEROL XINAFOATE 50 MCG DRY POWDER INHALER COMPARED TO ADMINISTRATION WITH ADVAIR DISKUS 10050 MCG TWICE DAILY AND PLACEBO IN PATIENTS 12 YEARS OF AGE AND OLDER WITH REVERSIBLE PERSISTENT ASTHMA INCLUDING A 3-WEEK OPEN-LABEL EXTENSION TO ASSESS INHALER ROBUSTNESS Lupin Inc. $2,500 1

About Dr. Michael Ruff, MD

Dr. Michael Ruff, MD is a Allergy healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679532576.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Ruff, MD has received a total of $8,871 in payments from pharmaceutical and medical device companies, with $518.47 received in 2024. These payments were reported across 346 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,371).

Practice Information

  • Specialty Allergy
  • Location Dallas, TX
  • Active Since 03/20/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207KA0200X
  • Entity Type Individual
  • NPI Number 1679532576

Products in Payments

  • ADVAIR (Drug) $2,500
  • DUPIXENT (Biological) $734.61
  • ALVESCO (Drug) $640.43
  • TRELEGY ELLIPTA (Drug) $427.12
  • SYMBICORT (Drug) $304.13
  • CUTAQUIG (Biological) $299.01
  • RUCONEST (Biological) $258.26
  • BREO (Drug) $235.24
  • NUCALA (Biological) $224.04
  • FASENRA (Biological) $220.78
  • Odactra (Drug) $212.71
  • AUVI-Q (Drug) $195.15
  • BREZTRI (Drug) $174.80
  • DUPIXENT (Drug) $152.18
  • Xembify (Biological) $149.63
  • EUCRISA (Drug) $139.55
  • Xhance (Drug) $118.67
  • FASENRA (Drug) $108.04
  • TAKHZYRO (Biological) $106.71
  • QVAR (Drug) $98.82

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Allergy Doctors in Dallas